Harnessing alcohol side-chain reactivity in peptides and proteins: serine- and threonine-specific cleavage and conjugation.

Authors

Pranabes Bhattacharyya, Moumita Ghosh, Soumitra Halder, Sandeep Kumar Dash, Krishnendu Maji, Rajib Sarkar

Published in

Organic & biomolecular chemistry. Aug 28, 2026. Epub Aug 28, 2026.

Abstract

The side-chain hydroxyl groups of serine and threonine represent versatile and underexploited reactive handles for the selective chemical manipulation of peptides and proteins, offering complementary alternatives to conventional cysteine- and lysine-directed bioconjugation. Over the past decades, significant advances have been made in harnessing the unique reactivity of these alcohol-bearing amino acids for site-selective cleavage, functionalization, and bioconjugation. This review summarizes the fundamental principles governing alcohol side-chain reactivity and highlights emerging strategies that exploit serine and threonine residues for precise biomolecular modification. Particular emphasis is placed on serine- and threonine-specific peptide bond cleavage methodologies, including oxidative, dehydrative, acyl-transfer, and metal-mediated transformations that proceed through reactive intermediates such as dehydroalanine (Dha) and dehydrobutyrine (Dhb), oxazolines, and activated esters. These approaches have enabled controlled peptide fragmentation and protein editing under mild conditions. In parallel, recent developments in conjugation chemistry based on hydroxyl side-chain activation are discussed, encompassing glycosylation, phosphorylation-inspired modification, radical-mediated functionalization, and Dha/Dhb-based diversification. Such methods facilitate the site-selective installation of fluorophores, glycans, affinity tags, and therapeutic payloads onto complex biomolecular scaffolds. Collectively, the selective exploitation of serine and threonine side-chain reactivity has substantially expanded the toolbox of modern bioconjugate chemistry. These advances provide powerful opportunities in the areas of chemical biology, proteomics, biomaterials, and next-generation therapeutic development, while also offering new directions for selective peptide and protein engineering.

PMID:
42663093
Bibliographic data and abstract were imported from PubMed on 28 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.